Key facts
- This page summarizes Michael C. Skaff's Form 4 filing for Vivos Therapeutics, Inc. (VVOS).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 15 Jul 2026, 16:23.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date.
Footnote F2
Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
Footnote F3
On June 30, 2026, V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000 entered into between the reporting person and the Issuer into shares of the Issuer's Series A Convertible Preferred Stock, based on $0.456 per share plus $0.125 per share in accordance with the Nasdaq minimum price rules.